News tagged ‘TargetedTherapy’ clear
- Newly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.
Tags: ColonCancer, Genomics, KinaseInhibitor, LungCancer, TargetedTherapy
- Jessie M. English, PhD, has been appointed the head of Research of the Belfer Institute for Applied Cancer Science at Dana-Farber. The Belfer Institute offers the full array of innovative drug discovery capabilities, from the identification of cancer-causing genetic mutations to the validation and selection of new drug targets.
Tags: Genomics, LungCancer, TargetedTherapy, TranslationalResearch
- A multi-institutional team of researchers has published a study that demonstrates a novel therapy works against solid tumors. It is the first targeted and programmed nanomedicine to enter human clinical studies.
Tags: TargetedTherapy, TranslationalResearch
- Dana-Farber researchers report a novel compound has become the first targeted therapy to benefit patients with non-small cell lung cancer.
Tags: LungCancer, TargetedTherapy
- Regorafenib was found to reduce the risk of disease progression or death by more than 70 percent in patients whose tumors had become resistant to Gleevec and Sutent.
Tags: DrugResistance, Sarcoma, TargetedTherapy
- The Cancer Genome Atlas Research Network has identified a large number and variety of DNA alterations in squamous cell lung cancer tumors, which could serve as potential therapeutic targets for treating the second most common type of lung cancer.
Tags: Genomics, LungCancer, TargetedTherapy
- Bruce Johnson, MD, the director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, sorts out the facts about lung cancer and offers simple ways to reduce risk.
Tags: LungCancer, Smoking, TargetedTherapy, Genetics
- A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber who led the worldwide clinical trial.
Tags: KinaseInhibitor, Sarcoma, TargetedTherapy
- A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.
Tags: LungCancer, TargetedTherapy, Genetics
- Dana-Farber researchers found levels of galectin-1, an immunity-related protein, could be the basis of a test, and potentially a targeted treatment for Hodgkin lymphoma.
Tags: TargetedTherapy, Lymphoma
Showing 11-20 of 49 items